ArticleCureus2023
National Malaria Control Program in Bangladesh: 2007-2010.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Global Fund's Bangladesh program.IJID regions · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria is a life-threatening disease caused by the plasmodium parasite, which is transmitted to people by the bites of infected mosquitoes. As elsewhere, this disease is also a major public health problem in Bangladesh. After independence, dichlorodiphenyltrichloroethane (DDT) use was banned in 1985, and the number of malaria cases began to increase. There were no control programs and inadequate funds, especially in the malaria-endemic areas; thus, malaria cases started to be epidemic in the 1990s. The global fund has been supporting the National Malaria Control Program (NMCP) in Bangladesh since the approval of the round 6 malaria proposal in 2006. This study aims to review the NMCP and changes in the burden of malaria in Bangladesh from 2007 to 2010. This is a descriptive retrospective study based on the secondary malaria surveillance data (cases and deaths) in 13 malaria-endemic districts, especially five selected districts, Chittagong, Cox's Bazar, Rangamati, Sylhet, and Mymensingh. A descriptive analysis was carried out to establish the incidence and mortality rate. From 2007 to 2010, a total of 264,293 confirmed malaria cases were notified from 13 malaria-endemic districts. More than 50% of the affected population was under the age group of ≥15 years (55.7%). Males had a higher risk of contracting of malaria than females, accounting for 53.5% of confirmed cases compared to 46.5% of females. Among the affected population,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.